Study questions value of genetic advice on breast cancer in primary care

January 03, 2001

The value of giving genetic advice on breast cancer in primary care is questionable, according to a study in this week's BMJ.

Researchers in the Netherlands studied women's compliance with advice provided by their general practitioner that was based on assessment of genetic risk and whether this genetic advice was in line with the advice of a clinical geneticist.

Their findings question the value of giving genetic advice on breast cancer in primary care. Firstly, women showed a low level of compliance with genetic advice given by their general practitioner. Secondly, the geneticist's advice was not followed by the general practitioner in 30% of the consultations and, thirdly, there is no evidence that surveillance is effective in women under 50. Nevertheless, the authors believe that there is a place for genetic advice in general practice and that further research could improve its effectiveness.
-end-
Contact: Geertruida H de Bock, Epidemiologist, Leiden University Medical Centre, Leiden, Netherlands c/o Dirk Ketting (the promotor of the organisation LUMC) Tel: 31-71-5268005/e-mail dketting@LUMC.NL

(How women with a family history of breast cancer and their general practitioners act on genetic advice in general practice: prospective longitudinal study) BMJ Volume 322, pp 26-27

This release is reproduced verbatim and with permission from the British Medical Association as a service to reporters interested in health and behavioral change. Please contact Public Affairs Division for the text of the paper, and the authors direct for further comment. For further information about The British Medical Journal or to obtain a copy of the article, please contact Public Affairs Division, British Medical Association, BMA House, Tavistock Square, London WC1H 9JP, Tel: 020-7383-6254 or email: pressoffice@bma.org.uk. After 6 p.m. and on weekends telephone: 44-0-208-241-6386/44-0-208-997-3653/44-0-208-674-6294/44-0-1525-379792/44-0208-651-5130.

Posted by the Center for the Advancement of Health http://www.cfah.org. For information about the Center, call Petrina Chong, pchong@cfah.org 202-387-2829.

Center for Advancing Health

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.